Literature DB >> 3021050

High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue.

R E Bawdon, P O Madsen.   

Abstract

A reverse-phase high-pressure liquid chromatography method for the quantitation of sulbactam in plasma, urine, and tissue is described. The assay used the formation of an imidazole derivative followed by extraction with acetonitrile and dichloromethane and used UV absorbance for detection. The mobile phase consisted of acetonitrile, tetrabutylammonium hydroxide, and phosphate buffer. The assay was linear from 100 micrograms/ml (g of tissue) to 1 microgram/ml (g). Within- and between-batch recovery was greater than 90%. The coefficient of variation was generally less than 15%. There were no interfering peaks in the quantitation of sulbactam.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021050      PMCID: PMC180524          DOI: 10.1128/AAC.30.2.231

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).

Authors:  R Labia; V Lelievre; J Peduzzi
Journal:  Biochim Biophys Acta       Date:  1980-02-14

2.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

3.  Comparison of cefoperazone and cefoxitin concentrations in serum and pelvic tissue of abdominal hysterectomy patients.

Authors:  R E Bawdon; D L Hemsell; S P Guss
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

4.  Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.

Authors:  C Kemal; J R Knowles
Journal:  Biochemistry       Date:  1981-06-23       Impact factor: 3.162

  4 in total
  7 in total

1.  Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.

Authors:  R A Blum; R K Kohli; N J Harrison; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Pharmacodynamics modeling to optimize dosage regimens of sulbactam.

Authors:  Sutep Jaruratanasirikul; Wibul Wongpoowarak; Nanchanit Aeinlang; Monchana Jullangkoon
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

3.  Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.

Authors:  C Martin; A Cotin; A Giraud; M Beccani-Argème; P Alliot; M N Mallet; M Argème
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

5.  Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.

Authors:  L B Rice; L L Carias; L Etter; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

6.  Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep.

Authors:  E Escudero; A Espuny; S Vicente; C M Cárceles
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

7.  A novel high performance liquid chromatographic method for simultaneous determination of ceftriaxone and sulbactam in sulbactomax.

Authors:  Sanjay Mohan Shrivastava; Rajkumar Singh; Abu Tariq; Masoom Raza Siddiqui; Jitendar Yadav; P S Negi; Manu Chaudhary
Journal:  Int J Biomed Sci       Date:  2009-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.